Gerresheimer reported a lower core profit for the first half of 2026, with EBITDA dropping to €168 million from €210.4 million previously. Weakness in its Moulded Glass business and reduced demand for
German drug packaging firm Gerresheimer will sell its U.S. unit Centor and global primary packaging plastics business to Apax for €1.5 billion to optimize its capital structure. The sale follows inter
German medical packaging maker Gerresheimer has rejected a takeover bid from rival Silgan, ending negotiations as the company focuses on resolving accounting issues and selling its U.S. subsidiary Cen
ChemBrief